Back to search

Peptide record

TPDB23200

Antibacterial Antiviral Toxicity standard
13 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB23200
Antibacterial Antiviral Toxicity
Anti-infective peptides Toxicity and safety peptides
Peptipedia AI4AVP dbAMP 3.0 DRAVP 2.0
standard
No
A 13-aa standard natural multi-activity (Antibacterial, Antiviral, and Toxicity) peptide sequence curated from Peptipedia, AI4AVP, dbAMP 3.0, and other sources, with an available 3D structural model.
Sequence
LWHHIWHTVHHLI
Physicochemical Analysis
C85H117N25O15
ARNDCEQGKMFPSY
H
1729.02
8.20
5
0
7
+0
-0.43
0.177
142.31
Mammalian: 5.5 hour Yeast: 3 min E.coli: 2 min
11000
636.20
1
Residue Composition
number
0
A
0
R
0
N
0
D
0
C
0
E
0
Q
0
G
5
H
2
I
2
L
0
K
0
M
0
F
0
P
0
S
1
T
2
W
0
Y
1
V
Amino Acid Distribution
A: 0 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 5 I: 2 L: 2 K: 0 M: 0 F: 0 P: 0 S: 0 T: 1 W: 2 Y: 0 V: 1
Chemical Descriptors
13
C85H117N25O15
1729.02
8.20
+0
-0.43
0.177
Evidence Records 3 records
Evidence 1 Activity

Activity

50% Cytotoxicity
Toxicity
106.68 µg/mL
Cytotoxic
50% Cytotoxicity | 106.68 | µg/mL | target cell: Vero cells

Target

Vero cells

Source & Reference

NA
DBAASP
Histidine-rich Modification of a Scorpion-derived Peptide Improves Bioavailability and Inhibitory Activity against HSV-1. | Theranostics | 2018
Evidence 2 Activity

Activity

Toxicity
Cytotoxic
Cytotoxicity: [Ref.29290802]Vero cell:CC50=106.68 µg/mL.

Source & Reference

NA
DRAMP
Theranostics. 2018 Jan 1 8(1):199-211.
Evidence 3 Activity

Activity

Toxicity
Cytotoxic
Cytotoxicity: [Ref.29290802]Vero cells: CC50 = 106.68 µg/mL.

Source & Reference

NA
DRAMP
Theranostics. 2018 Jan 1 8(1):199-211.